1089 related articles for article (PubMed ID: 11860399)
1. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
[TBL] [Abstract][Full Text] [Related]
2. [Helicobacter pylori--2002].
Treiber G; Malfertheiner P
Praxis (Bern 1994); 2002 May; 91(18):773-8. PubMed ID: 12071078
[TBL] [Abstract][Full Text] [Related]
3. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.
Malfertheiner P; Megraud F; O'Morain C; Bazzoli F; El-Omar E; Graham D; Hunt R; Rokkas T; Vakil N; Kuipers EJ
Gut; 2007 Jun; 56(6):772-81. PubMed ID: 17170018
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
5. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Rosengren H; Polson RJ
Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
[TBL] [Abstract][Full Text] [Related]
6. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
Gut; 1997 Jul; 41(1):8-13. PubMed ID: 9274464
[TBL] [Abstract][Full Text] [Related]
7. Key points from the revised Maastricht Consensus Report: the impact on general practice.
Bazzoli F
Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S3-7. PubMed ID: 11686230
[TBL] [Abstract][Full Text] [Related]
8. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
9. One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Hung WK; Wong WM; Wong GS; Yip AW; Szeto ML; Lai KC; Hu WH; Chan CK; Xia HH; Yuen MF; Fung FM; Tong TS; Ho VY; Lam SK; Wong BC
Aliment Pharmacol Ther; 2002 Dec; 16(12):2067-72. PubMed ID: 12452939
[TBL] [Abstract][Full Text] [Related]
10. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection--current treatment practice.
Xia HH; Yu Wong BC; Talley NJ; Lam SK
Expert Opin Pharmacother; 2001 Feb; 2(2):253-66. PubMed ID: 11336584
[TBL] [Abstract][Full Text] [Related]
12. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
[TBL] [Abstract][Full Text] [Related]
13. Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Gisbert JP; Boixeda D; Martín De Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
Scand J Gastroenterol; 1997 Jul; 32(7):643-50. PubMed ID: 9246702
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and gastric or duodenal ulcer.
Prescrire Int; 2016 Jan; 25(167):18-23. PubMed ID: 26942258
[TBL] [Abstract][Full Text] [Related]
15. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
[TBL] [Abstract][Full Text] [Related]
17. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
18. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
Schütze K; Hentschel E; Hirschl AM
Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
20. [Helicobacter pylori - 2012].
Buzás GM
Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]